Ahmad E, Lim S, Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet. 2022;400(10365):1803–20.
Magliano DJ, Boyko EJ. committee IDFDAtes: IDF Diabetes Atlas. In: Idf diabetes atlas Brussels: International Diabetes Federation © International Diabetes Federation, 2021.; 2021.
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, Beguinot F, Miele C. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci 2019, 20(9).
Jensen MD. Visceral Fat: culprit or Canary? Endocrinol Metab Clin North Am. 2020;49(2):229–37.
Lee SW, Son JY, Kim JM, Hwang SS, Han JS, Heo NJ. Body fat distribution is more predictive of all-cause mortality than overall adiposity. Diabetes Obes Metab. 2018;20(1):141–7.
Article CAS PubMed Google Scholar
Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715–25.
Moh A, Neelam K, Zhang X, Sum CF, Tavintharan S, Ang K, Lee SBM, Tang WE, Lim SC. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic asian cohort with longstanding type 2 diabetes. Endocr Res. 2018;43(3):186–94.
Xu L, Song P, Xu J, Zhang H, Yu C, Guan Q, Zhao M, Zhang X. Viscus fat area contributes to the Framingham 10-year general cardiovascular disease risk in patients with type 2 diabetes mellitus. Life Sci. 2019;220:69–75.
Article CAS PubMed Google Scholar
Omura-Ohata Y, Son C, Makino H, Koezuka R, Tochiya M, Tamanaha T, Kishimoto I, Hosoda K. Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):137.
Article PubMed PubMed Central Google Scholar
Wang Y, Chen F, Wang J, Wang T, Zhang J, Han Q, Wu Y, Zhang R, Liu F. The relationship between increased ratio of visceral-to-Subcutaneous Fat Area and Renal Outcome in chinese adults with type 2 diabetes and Diabetic kidney disease. Can J Diabetes. 2019;43(6):415–20.
Wan H, Wang Y, Xiang Q, Fang S, Chen Y, Chen C, Zhang W, Zhang H, Xia F, Wang N, et al. Associations between abdominal obesity indices and diabetic complications: chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol. 2020;19(1):118.
Article PubMed PubMed Central Google Scholar
Park HJ, Shin Y, Park J, Kim H, Lee IS, Seo DW, Huh J, Lee TY, Park T, Lee J, et al. Development and validation of a deep learning system for segmentation of abdominal muscle and Fat on Computed Tomography. Korean J Radiol. 2020;21(1):88–100.
Lee JJ, Pedley A, Hoffmann U, Massaro JM, Keaney JF Jr, Vasan RS, Fox CS. Cross-sectional Associations of computed tomography (CT)-Derived adipose tissue density and adipokines: the Framingham Heart Study. J Am Heart Assoc. 2016;5(3):e002545.
Article PubMed PubMed Central Google Scholar
Yang Q, Zhang M, Sun P, Li Y, Xu H, Wang K, Shen H, Ban B, Liu F. Cre/CysC ratio may predict muscle composition and is associated with glucose disposal ability and macrovascular disease in patients with type 2 diabetes. BMJ Open Diabetes Res Care 2021, 9(2).
Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020. 4678526.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, Zhang W, Wang L, Zhang Y, Ren Z, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.
Article PubMed PubMed Central Google Scholar
Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the korean genome and epidemiology study cohort. Transl Res. 2021;228:42–51.
Article CAS PubMed Google Scholar
Chamroonkiadtikun P, Ananchaisarp T, Wanichanon W. The triglyceride-glucose index, a predictor of type 2 diabetes development: a retrospective cohort study. Prim Care Diabetes. 2020;14(2):161–7.
Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134.
Article CAS PubMed PubMed Central Google Scholar
Otsubo N, Fukuda T, Genhin C, Ishibashi F, Yamada T, Monzen K. Utility of Indices Obtained During Medical Checkups for Predicting Fatty Liver Disease in Non-obese People. Internal medicine (Tokyo, Japan) 2022.
Albersheim J, Sathianathen NJ, Zabell J, Renier J, Bailey T, Hanna P, Konety BR, Weight CJ. Skeletal muscle and Fat Mass indexes predict Discharge Disposition after Radical Cystectomy. J Urol. 2019;202(6):1143–9.
Huo L, Li K, Deng W, Wang L, Xu L, Shaw JE, Jia P, Zhou D, Cheng XG. Optimal cut-points of visceral adipose tissue areas for cardiometabolic risk factors in a chinese population: a cross-sectional study. Diabet Med. 2019;36(10):1268–75.
Article CAS PubMed Google Scholar
Xu S, Ming J, Jia A, Yu X, Cai J, Jing C, Liu C, Ji Q. Normal weight obesity and the risk of diabetes in chinese people: a 9-year population-based cohort study. Sci Rep. 2021;11(1):6090.
Article PubMed PubMed Central Google Scholar
Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5(1):11–8.
Article PubMed PubMed Central Google Scholar
Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018;21(5):360–5.
Article PubMed PubMed Central Google Scholar
Neeland IJ, Poirier P, Després JP. Cardiovascular and metabolic heterogeneity of obesity: Clinical Challenges and Implications for Management. Circulation. 2018;137(13):1391–406.
Article PubMed PubMed Central Google Scholar
Du T, Sun X, Huo R, Yu X. Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes (Lond). 2014;38(6):840–7.
Article CAS PubMed Google Scholar
Tian YM, Ma N, Jia XJ, Lu Q. The “hyper-triglyceridemic waist phenotype” is a reliable marker for prediction of accumulation of abdominal visceral fat in chinese adults. Eat Weight Disord. 2020;25(3):719–26.
Cunha de Oliveira C, Carneiro Roriz AK, Eickemberg M, Barreto Medeiros JM, Barbosa Ramos L. Hypertriglyceridemic waist phenotype: association with metabolic disorders and visceral fat in adults. Nutr Hosp. 2014;30(1):25–31.
Sam S, Haffner S, Davidson MH, D’Agostino RB, Sr., Feinstein S, Kondos G, Perez A, Mazzone T. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32(10):1916–20.
Article CAS PubMed PubMed Central Google Scholar
Wu Z, Yu S, Kang X, Liu Y, Xu Z, Li Z, Wang J, Miao X, Liu X, Li X, et al. Association of visceral adiposity index with incident nephropathy and retinopathy: a cohort study in the diabetic population. Cardiovasc Diabetol. 2022;21(1):32.
Article CAS PubMed PubMed Central Google Scholar
Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and Cardiovascular Diseases. Circ Res. 2020;126(11):1477–500.
Abraham TM, Pedley A, Massaro JM, Hoffmann U, Fox CS. Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors. Circulation. 2015;132(17):1639–47.
Article CAS PubMed PubMed Central Google Scholar
Liu J, Fox CS, Hickson DA, May WD, Hairston KG, Carr JJ, Taylor HA. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95(12):5419–26.
Article CAS PubMed PubMed Central Google Scholar
Kim S, Cho B, Lee H, Choi K, Hwang SS, Kim D, Kim K, Kwon H. Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a korean population. Diabetes Care. 2011;34(2):504–6.
Article PubMed PubMed Central Google Scholar
Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55(10):2622–30.
Article CAS PubMed PubMed Central Google Scholar
Katsuyama H, Kawaguchi A, Yanai H. Not visceral fat area but the ratio of visceral to subcutaneous fat area is significantly correlated with the marker for atherosclerosis in obese subjects. Int J Cardiol. 2015;179:112–3.
Narumi H, Yoshida K, Hashimoto N, Umehara I, Funabashi N, Yoshida S, Komuro I. Increased subcutaneous fat accumulation has a protective role against subclinical atherosclerosis in asymptomatic subjects undergoing general health screening. Int J Cardiol. 2009;135(2):150–5.
Fukuda T, Bouchi R, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Ratio of vis
留言 (0)